Antony Pfaffle, Interim Chief Medical Officer at CorMedix Inc. (CRMD), sold 29,600 shares at $2.84 ($85K) on 2016-05-20, disclosed to the SEC on 2016-05-24.
Open-market sale of $85k CRMD by Interim Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.84 | 3,201 | $9K | 10.6% |
| 2 | $2.84 | 3,201 | $9K | 10.7% |
| 3 | $2.89 | 400 | $1K | 1.4% |
| 4 | $2.92 | 6,399 | $19K | 21.9% |
| 5 | $2.92 | 6,399 | $19K | 21.9% |
| 6 | $2.87 | 5,000 |
| $14K |
| 16.8% |
| 7 | $2.87 | 5,000 | $14K | 16.8% |
| Total | $2.89 avg | 29,600 | $85K | 100% |
| Filing → |
| CRMD | SELL | 2016-06-22 | $127K | — | Filing → |
| CRMD | SELL | 2016-06-16 | $11K | — | Filing → |
| CRMD | SELL | 2016-06-14 | $12K | — | Filing → |